Suppliers in Trinidad, CO
8 Medicare Suppliers found. Showing 1 - 8
 Lincare Inc Medicare Supplier Location: 916 Arizona Ave, Trinidad, Colorado 81082 Phone: (719) 846-7648 |
Medco Professional Services Corp Durable Medical Equipment & Medical Supplies Location: 401 East Main St, Trinidad, Colorado 81082 Phone: (719) 846-8328 |
Walmart Pharmacy 10-0962 Durable Medical Equipment & Medical Supplies Location: 2921 Toupal Dr, Trinidad, Colorado 81082 Phone: (719) 846-3358 |
Safeway Pharmacy #0722 Durable Medical Equipment & Medical Supplies Location: 457 W Main St, Trinidad, Colorado 81082 Phone: (719) 846-3086 |
Cobigred Inc Durable Medical Equipment & Medical Supplies Location: 824e Main St, Trinidad, Colorado 81082 Phone: (719) 845-0069 |
Aerocare Holdings, Inc. Durable Medical Equipment & Medical Supplies Location: 2006 Freedom Rd, Trinidad, Colorado 81082 Phone: (719) 845-1986 |
Sleep Well Southern Colorado Treatm DME Supplier - Customized Equipment Location: 417 University St, Trinidad, Colorado 81082 Phone: (719) 846-7387 |
Rocky Mountain Eye Center Inc, A Co Medicare Supplier Location: 2116 Freedom Rd, Trinidad, Colorado 81082 Phone: (719) 846-9236 |
News Archive
Study uncovers mechanism by which Notch pathway could contribute to RA
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under development for diseases such as cancer could potentially be used to treat RA.
New clinical trial to evaluate efficacy of stem cell product in patients disabled with chronic stroke
A clinical trial to evaluate the safety and efficacy of a stem cell product injected directly into the brain to treat chronic motor deficits from ischemic stroke has begun at McGovern Medical School at The University of Texas Health Science Center at Houston.
AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
Five-year $10.7M grant to study control, prevention of sexually-transmitted infections
The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).
First Edition: January 5, 2012
Today's headlines include a report that health law opponents want to add plaintiffs to their lawsuit as well as dispatches from the GOP primary election compaign trail.
› Verified 8 days ago